AllianceBernstein’s Cellular Biomedicine Group, Inc. CBMG Stock Holding History

AllianceBernstein’s Portfolio CBMG Stock Details CBMG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-12,900	Closed	-$237K	–	3355
2020 Q4	$237K	Hold	12,900	–	–	﹤0.01%	2945
2020 Q3	$237K	Sell	12,900 -2,400	-16%	-$40.3K	﹤0.01%	2914
2020 Q2	$229K	Buy	+15,300	New	+$219K	﹤0.01%	2972

AllianceBernstein's CBMG Position: Q1 2021 in Review

AllianceBernstein sold out of Cellular Biomedicine Group, Inc. (CBMG) in Q1 2021, closing a stake of 12,900 shares — an estimated $237K sold.

AllianceBernstein first reported a position in CBMG in Q2 2020 and held it in 3 quarters. The position peaked at $237K in Q4 2020. 0 funds tracked by Wall St. Rank hold CBMG as of Q1 2021.

AllianceBernstein reported no remaining Cellular Biomedicine Group, Inc. position as of Q1 2021 after selling out during the quarter.
AllianceBernstein sold 12,900 Cellular Biomedicine Group, Inc. shares in Q1 2021, an estimated $237K.
AllianceBernstein first reported a position in Cellular Biomedicine Group, Inc. in Q2 2020 and held it in 3 quarters.
AllianceBernstein's Cellular Biomedicine Group, Inc. position peaked at $237K in Q4 2020.
0 funds tracked by Wall St. Rank held Cellular Biomedicine Group, Inc. as of Q1 2021.

Based on AllianceBernstein's 13F filing for Q1 2021, filed 6 May 2021.